WVE - Bagan rega target Wave Life Sciences Ltd

Wave Life Sciences (WVE) specializes in developing gene therapies, where success depends on the PRISM platform and funding from major partners. AI algorithms and automation optimize the development process, although final tests remain the responsibility of medical professionals. The current consensus forecast is 18.40. This price chart illustrating value trends visualizes the market dynamics of this biotech project.

WVE Prakiraan konsensus analis Wave Life Sciences Ltd (04.07.2022 - 22.10.2026)

Rincian analitis perusahaan Wave Life Sciences Corp (WVE)

Indikator analitis utama Wave Pharma (WVE):

Kutipan saham wavelifesciences.com|WVE - Target konsensus|Nilai pasar Wave Life Sciences Corp

Ringkesan analitik perusahaan:WVE (wavelifesciences.com)

Produk sing diprodhuksi Wave Life Sciences Corp

Wave Life Sciences reduces genetic risks by creating precision RNA therapeutics based on its proprietary DNA synthesis. This indicator calculates the arithmetic mean of Wall Street analysts' target prices to determine the asset's fair value. A significant gap between the market price and the valuation signals either an undervaluation or hidden issues within the issuer. Investors utilize this discount to calculate the position's margin of safety. By analyzing the consensus valuation benchmark for the stock, one can assess the potential for price appreciation.

Perusahaan pesaing

Target konsensus tempus.com TEM|Qiagen - Target konsensus|Ionis Pharmaceuticals, Inc. - Bagan rega target|Repligen Corp. - Prakiraan konsensus analis|Rata-rata rega prakiraan Avidity Corp|CRSP: Prakiraan konsensus analis|Prakiraan gabungan firma investasi WGS|Bagan rega target Ultragenyx|Prakiraan gabungan firma investasi BEAM (Beam Therapeutics Inc)|Prakiraan konsensus analis SRPT|Prakiraan konsensus analis Twist Bioscience Corp (TWST)|10x Genomics, Inc. - Target konsensus|NTLA - Target konsensus|Stoke Therapeutics, Inc. - Prakiraan konsensus analis|BLFS - Prakiraan konsensus analis|MAZE (Maze Tx) - Target konsensus|SION (Sionna Corp) - Bagan rega target|PRME (Prime Medicine, Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan tayshagtx.com TSHA|Target konsensus QURE (uniQure)|MGTX (MeiraGTx Holdings) - Konsensus nilai wajar|Bagan rega target Regenxbio RGNX|Solid Corp - Bagan rega target|Ocugen, Inc. - Prakiraan konsensus analis|Target median analis pacb.com PACB|BNTC: Prakiraan konsensus analis|Bagan tingkat prakiraan DSGN (Design Therapeutics Inc)|RCKT (Rocket Pharmaceuticals Inc) - Prakiraan konsensus analis|Rata-rata rega prakiraan 4D Molecular Corp FDMT|Target konsensus LXEO (Lexeo Therapeutics)|KRRO (korrobio.com) - Konsensus nilai wajar|Bagan rega target Editas Medicine EDIT|Target median analis Silence Therapeutics PLC (SLN)|ProQR Therapeutics NV - Prakiraan konsensus analis|Codexis, Inc. (CDXS) - Target konsensus|SGMO: Prakiraan konsensus analis|NAUT - Target median analis|MGX (Metagenomi) - Prakiraan konsensus analis|Rata-rata rega prakiraan Precision BioSciences Inc. DTIL|Bagan rega target Generation Bio Co. (GBIO)|Boundless Bio Inc - Prakiraan gabungan firma investasi|Prakiraan konsensus analis XCUR (Exicure)|IMNN - Target konsensus|RXi Pharmaceuticals - Prakiraan konsensus analis|Rata-rata rega prakiraan Mustang Bio, Inc.|transcodetherapeutics.com (RNAZ) - Bagan rega target|BNGO - Target median analis|Target konsensus APDN|Target konsensus bluebirdbio.com (BLUE)|Target konsensus IPA (ImmunoPrecise Antibodies)|Bagan rega target OMGA (Omega Therapeutics Inc)|Prakiraan konsensus analis OMIC (Singular Genomics Systems Inc)|Regulus (RGLS) - Rata-rata rega prakiraan|Syros Pharmaceuticals - Prakiraan konsensus analis|TBIO (telesisbio.com) - Prakiraan gabungan firma investasi|TRACON Pharmaceuticals, Inc. (TCON) - Bagan rega target|Prakiraan gabungan firma investasi UBX